Anaferon children's tab. # 20

With prophylactic and therapeutic use, the drug has an immunomodulatory and antiviral effect. Efficacy against influenza viruses, herpes viruses (chickenpox, infectious mononucleosis), rotavirus has been experimentally and clinically established. The drug reduces the concentration of the virus in the affected tissues, affects the system of endogenous interferons and associated cytokines, induces the formation of endogenous early" interferons (IFN a /?) And gamma-interferon (IFN?). Stimulates the humoral and cellular immune response. Increases the production of antibodies (including secretory IgA), activates the functions of T-effectors, T-helpers (Tx), and normalizes their ratio. Increases the functional reserve of Th and other cells involved in the immune response. It is an inducer of a mixed Txl and Tx2-type immune response:increases the production of cytokines Txl (IFN?, IL-2) and РўС�2 (IL-4, 10), normalizes (modulates) the balance of РўС�1 / РўС�2 activities. Increases the functional activity of phagocytes and natural killer cells (EK cells).

Name ENG

ANAFERON KID

Clinical and pharmacological group

Antiviral drug.

Immunomodulator

ATX code

Immunostimulants, Other antiviral drugs

Dosage

3mg

Structure

Affinity purified antibodies to human gamma interferon - 0.003 g *.

Excipients: lactose, microcrystalline cellulose, magnesium stearate.

* introduced in the form of a water-alcohol mixture of the active form of the active substance ***.

** The active form of the active substance is the active form with a content of not more than 10-16 ng / g of the active substance.

Indications

Prevention and treatment of acute respiratory viral infections (including influenza).

Complex therapy of infections caused by herpes viruses (infectious mononucleosis, chickenpox, labial herpes, genital herpes).

Complex therapy and prevention of recurrence of chronic herpesvirus infection, including labial and genital herpes.

Complex therapy and prevention of other acute and chronic viral infections caused by tick-borne encephalitis virus, enterovirus, rotavirus, coronavirus, calicivirus.

Application in the complex therapy of bacterial infections.

Complex therapy of secondary immunodeficiency states of various etiologies, including prevention and treatment of complications of viral and bacterial infections.

INN / Active ingredient

affinity purified antibodies to human interferon gamma

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 3 years

Contraindications

Increased individual sensitivity to the components of the drug. Children under 1 month old - for the prevention and treatment of influenza and ARVI in children. Children under 1 year old - for the treatment of infections caused by herpes viruses in children. Children up to 6 months old - for the treatment of acute intestinal infection caused by rotavirus. Lactase deficiency, lactose intolerance, glucose-galactose malabsorption.

Specifications

Category

Homeopathy

Scope of the drug

General

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

twenty

Minimum age from

1 month

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Materia Medica Holding

The amount of the dosage form in the primary package

20 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Immunostimulating agent

Anatomical and therapeutic characteristics

L03 Immunostimulants

Dosage form

Lozenges

Expiration date in days

1095

The target audience

Children

Package weight, g

twenty

Mode of application

:

Inside. At a time - 1 tablet (keep in the mouth until completely dissolved - not during meals). Children from 1 month. When prescribing the drug to young children (from 1 month to 3 years), it is recommended to dissolve the tablet in a small amount (1 tablespoon) of boiled water at room temperature. SARS, influenza, intestinal infections, herpesvirus infections, neuroinfections. Treatment should be started as early as possible - when the first signs of an acute viral infection appear according to the following scheme: in the first 2 hours, the drug is taken every 30 minutes, then during the first day three more doses are taken at regular intervals. From the second day onwards, take 1 tablet 3 times a day until complete recovery. In the absence of improvement,on the third day of treatment with the drug for acute respiratory viral infections and influenza, you should consult a doctor. In the epidemic season, for prophylactic purposes, the drug is taken daily 1 time per day for 1-3 months. Genital herpes. In case of acute manifestations of genital herpes, the drug is taken at regular intervals according to the following scheme: 1-3 days - 1 tablet 8 times a day, then 1 tablet 4 times a day for at least 3 weeks. For the prevention of recurrence of chronic herpesvirus infection - 1 tablet per day. The recommended duration of the prophylactic course is determined individually and can be up to 6 months. When using the drug for the treatment and prevention of immunodeficiency states, in the complex therapy of bacterial infections - take 1 tablet per day.If necessary, the drug can be combined with other antiviral and symptomatic agents.

Dosage (volume) of the substance in the preparation

:

1 tab.

- antibodies to human gamma interferon affinity purified 0.003 g

Information on technical characteristics, delivery set, country of manufacture "